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The Salmonella enterica serovar Typhi tsx gene encodes a porin that facilitates the import of nucleosides.
When serovar Typhi is grown under anaerobic conditions, Tsx is among the outer membrane proteins whose
expression increases dramatically. This increase in expression is due, at least in part, to increased transcrip-
tion and is dependent on Fnr but not on ArcA. A mutant derivative of serovar Typhi strain STH2370 with a
deletion of the tsx gene is an auxotroph that requires either adenosine or thymidine for growth on minimal
medium. In contrast, an otherwise isogenic nupG nupC double mutant, defective in the inner membrane
nucleoside permeases, is a prototroph. Because anaerobic growth enhances the virulence of serovar Typhi in
vitro, we assessed the role that the tsx gene plays in pathogenicity and found that the serovar Typhi STH2370
tsx mutant is defective in survival within human macrophage-like U937 cells. To understand why the tsx
mutant is an auxotroph, we selected for insertions of minitransposon T-POP in the tsx genetic background
that restored prototrophy. One T-POP insertion that suppressed the tsx mutation in the presence of the
inducer tetracycline was located upstream of the pyrD gene. The results of reverse transcription-PCR analysis
showed that addition of the inducer decreased the rate of pyrD transcription. These results suggest that the Tsx
porin and the balance of products of the tsx and pyrD genes play critical roles in membrane assembly and
integrity and thus in the virulence of serovar Typhi.
Salmonella enterica serovar Typhi is a facultative intracellu-
lar pathogen that causes typhoid fever in humans. Salmonella
serovar Typhi infections are responsible for significant morbid-
ity and mortality worldwide, and there are an estimated 21.5
million cases per year, most of which occur in developing
countries (14). Systemic infection of mice by the closely related
bacterium Salmonella enterica serovar Typhimurium has been
studied as a model of the systemic infection caused by serovar
Typhi in humans, its only known host and reservoir.
To establish a successful infection, serovar Typhi must be
able to adapt to changing environmental conditions encoun-
tered within the human host and must respond to these con-
ditions by altering the expression of various genes (24, 27, 48,
64). Salmonella serovar Typhi virulence is enhanced in the
presence of low oxygen, high osmolarity, and alkaline pH,
conditions that apparently reflect the conditions encountered
in the host (2, 4, 15, 25, 39, 40).
The first step in the infection process involves contact be-
tween serovar Typhi and host cells. This step likely involves
initial interactions between the bacterial O antigen and specific
host cell surface receptors and subsequent interactions be-
tween the bacterial outer membrane proteins and the host cell.
The most abundant outer membrane proteins made by serovar
Typhi are the porins. These include OmpC and OmpF, which
have more general substrate specificities (6, 33, 54), and PhoE,
MalL (LamB), and Tsx, which facilitate the uptake of phos-
phates, maltodextrins, and nucleosides, respectively (16, 45,
71). Like OmpC and OmpF, the specialized porins are water-
filled channels and function without an energy requirement;
however, they contain saturable substrate-binding sites that
may limit transport at low substrate concentrations (8, 43, 53).
Once inside the host, intracellular pathogens like serovar
Typhi encounter an environment with a scarcity of nutrients,
including purines, pyrimidines, and aromatic amino acids (9,
20, 21, 28, 42, 47, 56). These pathogens can import nucleosides
to serve as precursors for nucleic acid synthesis (1, 30, 52); this
involves passive transport of the molecules across the outer
membrane into the periplasm, mediated by the Tsx porin, and
their active transport across the inner membrane into the cy-
toplasm, mediated by the permeases NupC and NupG (13, 50,
55, 73).
In this paper, we show that expression of the serovar Typhi
Tsx porin is induced upon anaerobic growth, environmental
conditions encountered by Salmonella inside the host (11, 25,
37). To understand the role that Tsx plays in the physiology
and pathogenicity of serovar Typhi, we constructed a mutant of
a clinical isolate of serovar Typhi with a deletion of the tsx
gene. To our surprise, we found that this deletion conferred an
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auxotrophic requirement for nucleosides and reduced the abil-
ity of serovar Typhi to survive within human U937 cells.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The serovar Typhi and sero-
var Typhimurium strains used in this study are derivatives of wild-type strains
STH2370 and 14028s, respectively, and are listed in Table 1. Bacteria were grown
routinely at 37°C with aeration by vigorous shaking. Anaerobiosis was achieved
by use of GasPack anaerobic jars. The rich medium used for growth was Luria-
Bertani (LB) medium (Bacto tryptone, 10 g liter1; Bacto yeast extract, 5 g
liter1; NaCl, 5 g liter1). The defined medium was M9-glucose medium
(NaH2PO4, 6 mg ml1; K2HPO4, 3 mg ml1; NH4Cl, 1 mg ml1; NaCl, 0.5 mg
ml1; MgSO4, 0.12 mg ml1; CaCl2, 0.015 mg ml1; glucose, 2 mg ml1) sup-
plemented with cysteine and tryptophan (50 mg liter1); this defined medium is
referred to below as “minimal medium.” When required, LB medium was sup-
plemented with ampicillin (100 mg liter1), tetracycline (10 mg liter1), chlor-
tetracycline (0.5 or 10 mg liter1), oxytetracycline (5 mg liter1), chloramphen-
icol (25 mg liter1), kanamycin (50 mg liter1), arabinose (2 mg ml1), and/or
glucose (2 mg ml1). Solid media included 1.5% agar (Agar-agar ultra pure;
Merck). Phosphate-buffered saline (PBS) contained NaH2PO4 · 7H2O (55 mg
ml1), K2HPO4 (15 mg ml1), and NaCl (4.25 mg ml1). Other reagents and
chemicals were obtained from Sigma. Escherichia coli strain DH5 {endA1
hsdR17 (r m) supE44 thi-1 recA1 gyrA(Nalr) relA1 (lacZYA-argF)U169 deoR
[80(lacZ)M15]} was used as the host for selection and preparation of plas-
mids.
Mutant construction. Mutant derivatives of serovar Typhi STH2370 with in-
sertions of Tn10 or MudJ in the ompC, ompF, fnr, arcA, or pyrD gene were
constructed from derivatives of serovar Typhimurium LT2 (MST2947, MST1082
[19], MST2970, MST2345, and MST248, respectively) by generalized transduc-
tion carried out at a low multiplicity of infection using the high-frequency trans-
ducing phage P22 HT105/1 int-201 (46, 61). Mutant strains with deletions of the
tsx, nupC, nupG, and ompA genes and concomitant insertions of kanamycin or
chloramphenicol cassettes were constructed using the method of Datsenko and
Wanner (17). Sixty-base PCR primers overlapping the start and stop codons of
each gene (boldface type) were synthesized with 40-base 5 ends corresponding
to the ends of the desired substitutions. The primers used for the genes were
tsx(H1P1) (CAGTGGCATACATATGAAAAAAACTTTACTCGCAGTCAG
CTGTAGGCTGGAGCTGCTTCG), tsx(H2P2) (CTTTTTTGCAGGTTTAG
AAGTTGTAACCCACGACCAGGTACATATGAATATCCTCCTTAG), nup
G(H1P1) (GGAAATTAACATGAATCTTAAGCTGCAGCTTAAAATACT
CTGTAGGCTGGAGCTGCTTCG), nupG(H2P2) (TATCCGGCCTGCGA
AACAGGGCAAGGATTAATGTGCAACGCATATGAATATCCTCCTT
AG), nupC(H1P1) (ATTTGGAGCAAATATGGACCGCGTCCTTCATTTT
GTCCTGTGTAGGCTGGAGCTGCTTCG), nupC(H2P2) (ATTAAACGC
AGACTTACAGTACCAGCGCCGCGATAGAGGCCATATGAATATCCTC
CTTAG), ompA(H1P1) (GGCGCATGCTGCCATGCGGCGGCGAGTCGC
GCCCACTTCATGTAGGCTGGAGCTGCTTCG), and ompA(H2P2) (GAG
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid(s) Genotype and/or phenotype Source
Salmonella serovar Typhi strains
STH2370 Wild type Hospital Lucio Co´rdova
TYT2053 STH2370 tsx::cam This study
TYT2075 STH2370 tsx This study
TYT2080 STH2370 tsx/pSU19::tsx This study
TYT2220 STH2370 nupC This study
TYT2214 STH2370 nupG This study
TYT2230 STH2370 nupG nupC This study
TYT3039 STH2370 pyrD::Tn10 This study
TYT2152 STH2370 ompC::Tn10 This study
TYT2160 STH2370 ompF::MudJ This study
TYT3033 STH2370 ompA This study
TYT3040 STH2370 tsx::lacZY This study
TYT3055 STH2370 tsx::lacZY fnr-2::Tn10 This study
TYT4567 STH2370 tsx::lacZY arcA::Tn10 This study
TYT2090 STH2370 tsx STY2025::T-POP This study
TYT2095 STH2370 tsx STY0014::T-POP This study
TYT2010 STH2370 tsx STY1399::T-POP This study
STH795 Wild type Hospital Lucio Co´rdova
TYT3020 STH795 tsx This study
Ty2 Laboratory strain S. Maloy
TYT4050 Ty2 tsx This study
Salmonella serovar Typhimurium strains
14028s Wild type S. Maloy
SC113 14028s tsx This study
LT2 Laboratory strain
MST2970 fnr-2::Tn10 S. Maloy
MST2345 arcA::Tn10 S. Maloy
MST2947 ompC::Tn10 S. Maloy
MST1062 ompF::MudJ S. Maloy
MST248 pyrD2260::Tn10 S. Maloy
MST1168 LT2/pNK972 S. Maloy
MST4208 F::T-POP S. Maloy
Plasmids
pSU19 Camr, medium-copy-number Cloning vector S. Maloy
pKD46 Ampr, Red recombinase expression plasmid K. Datsenko and B. Wanner
pCP20 Ampr, FLP recombinase expression plasmid K. Datsenko and B. Wanner
pKD4, pKD3 Camr and Kanr template plasmids K. Datsenko and B. Wanner
pCE36 Kanr, FRT::lacZY plasmid J. Slauch
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CAGAGTAGAATCAGCGGTAAGCCGGGGCAACCCGGTGCATATGAA
TATCCTCCTTAG).
The 3 20 bases of each primer (underlined) were annealed to the 5 and 3
ends of a chloramphenicol or kanamycin cassette flanked by the FRT sites
present in template plasmids pKD3 and pKD4 (17), respectively. PCRs using Taq
DNA polymerase were performed according to the manufacturer’s instructions
(Life Technologies). STH2370 carrying plasmid pKD46 (encoding the lambda
Red recombinase functions) was grown at 30°C in LB medium containing am-
picillin and 1 mM arabinose, made electrocompetent, and electroporated with
approximately 500 ng of each PCR product. Electroporated cells were plated on
LB medium with chloramphenicol or kanamycin at 37°C. Substitution mutations
in recombinant strains resulting from this procedure were moved into a clean
wild-type background by electroporation with linear chromosomal DNA. The
presence of each substitution mutation was confirmed by PCR amplification,
using primers complementary to the serovar Typhi genome flanking the sites of
substitution. After backcrossing, the resistance gene was eliminated using pCP20,
an ampicillin-resistant (Ampr) plasmid that is temperature sensitive for replica-
tion and induction of the FLP recombinase. Serovar Typhi Camr or Kanr mutants
were transformed with pCP20, Ampr recombinants were selected at 30°C, and
isolated colonies were purified at 37°C before tests for loss of antibiotic resis-
tance were performed.
Cloning and complementation of the serovar Typhi tsx gene. To clone the tsx
gene, we amplified a 1.6-kb fragment of serovar Typhi STH2370 DNA that
included the tsx coding sequence and its upstream promoter with primers TAG
AATTCTACGGGCAAATTCAGGGCACTA and CCGGATCCGGAAAGAG
AAAACCCCCGCACA. The PCR fragment was purified, digested with endo-
nucleases BamHI and KpnI, and ligated to the same sites of the Camr, medium-
copy-number plasmid vector pSU19 (69). The ligation mixture was
electroporated into E. coli host strain DH5, and recombinants that formed
white colonies on LB medium plates containing chloramphenicol with 0.5 mM
isopropyl--D-thiogalactopyranoside (IPTG) and 40 g/ml 5-bromo-4chloro-3-
indolyl--D-galactopyranoside (X-Gal) at 37°C were screened. Plasmid DNA
purified from one clone yielded an insert of the predicted size after digestion with
BamHI and KpnI. This plasmid, pSU19::tsx, was electroporated into serovar
Typhi tsx; Camr recombinants were shown to have the Tsx protein in their outer
membrane fractions (unpublished results).
Phenotypic analysis of the serovar Typhi tsx mutant. We used two different
assays to determine the phenotypes of the serovar Typhi tsx mutant and its
derivatives. Initially, we used a modification of the disk diffusion assay (5) to
determine the auxotrophic requirements of these strains. The strains were grown
overnight in LB medium with appropriate antibiotics, pelleted, washed twice with
PBS, and diluted 1:100 in PBS. Aliquots (200 l) containing approximately 2
	106 cells were spread on M9-glucose medium plates and allowed to dry. Twen-
ty-microliter portions of solutions of different nucleoside stocks (100 mM) were
spotted on filter paper disks, the disks were placed in the centers of the plates,
and the plates were incubated for 48 h at 37°C. The diameters of the zones of
growth were calculated by measuring along two axes passing through the center
of each disk.
To determine efficiencies of plating in the presence of nucleosides, overnight
cultures of wild-type and mutant cells grown in LB medium were pelleted,
washed twice with PBS, and diluted 106-fold in PBS. Aliquots (200 l) were
spread onto M9-glucose medium plates supplemented with cysteine and trypto-
phan and with adenosine, thymidine, guanosine, cytosine, inosine, or uridine at
final concentrations of 0.5 mM. The plates were incubated at 37°C for 48 h, and
the numbers of CFU were determined. Efficiencies of plating are expressed
below as the ratios of survival on media with nucleosides to survival on media
without nucleosides, divided by the titer of the wild-type strain without nucleo-
sides.
SDS-polyacrylamide gel analysis and N-terminal sequencing of proteins.
Outer membrane fractions were prepared as described by Lobos and Mora (44)
based on a modification of the method of Schnaitman (62), and proteins in these
fractions were separated in 12.5% polyacrylamide gels. Bacteria were grown to
the mid-exponential phase (optical density at 600 nm [OD600], 0.2), chilled on
ice, pelleted by centrifugation at 3,000 	 g for 15 min at 4°C, resuspended in lysis
buffer (10 mM Tris-HCl, pH 8, 10 mM MgCl2), and sonicated, and the prepa-
rations were supplemented with 2 mM phenylmethylsulfonyl fluoride. Whole
cells and debris were removed by low-speed centrifugation (3,000 	 g, 10 min),
and total membrane fractions were obtained after 45 min of centrifugation at
13,000 	 g at 4°C. Cytoplasmic membranes were solubilized with 2% Triton
X-100, and the outer membrane fraction was pelleted by centrifugation at 13,000
	 g and solubilized in 50 l of 100 mM Tris-HCl (pH 8 buffer), 1% sodium
dodecyl sulfate (SDS). For two-dimensional electrophoresis, outer membrane
fractions were resolved in the first dimension by SDS-polyacrylamide gel elec-
trophoresis (PAGE) and in the second dimension by isoelectric focusing by the
method of Hochstrasser et al. (35). Proteins in gels were stained with Coomassie
brilliant blue R-250. The protein content of each fraction was determined by the
bicinchoninic acid method (Pierce). Proteins in gels were electroblotted onto
polyvinylidene fluoride (Immobilon) membranes and detected by staining with
0.05% Coomassie brilliant blue R-250 in 50% methanol (high-performance liq-
uid chromatography grade). N-terminal amino acid sequences were determined
by sequential Edman degradation.
Assays for -galactosidase activity. Salmonella serovar Typhi mutant strains
with lacZY fusions were grown to an OD600 of 0.2 and then chilled to 4°C.
-Galactosidase activities were measured by a modification of the method of
Miller (49). Fifty microliters of each bacterial culture was suspended in 950 l of
Z buffer (0.6 M Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM
-mercaptoethanol; pH 7.0). The bacteria were permeabilized with 10 l chlo-
roform, 10 l 0.1% SDS, vortexed for 10 s, and incubated at 30°C for 10 min, and
200 l of o-nitrophenyl--D-galactopyranoside (4 mg/ml) was added. Reactions
were stopped by addition of 500 l 1 M Na2CO3. -Galactosidase activities are
expressed below in Miller units, 103 	 (A420  1.75 	 A550) ml1 min1 A6001.
Transposon mutagenesis. T-POP (58) mutagenesis was carried out as de-
scribed by Hidalgo et al. (32), using STH2370 tsx (pNK972) as the recipient.
The recipient was constructed by electroporation of plasmid pNK972 DNA
isolated from strain MST1168, followed by selection for Ampr recombinants at
30°C. Equal volumes of an overnight culture of Ampr recipient cells and a
generalized transducing lysate grown on donor strain MST4208 were mixed,
incubated for 2 h at 37°C, and then spread onto M9 medium plates containing
tetracycline. Colonies recovered after 48 h were used to grow overnight cultures
in M9 medium containing tetracycline. Chromosomal DNA purified from these
cultures was used to electroporate the serovar Typhi parental strain, STH2370
tsx, as described by Toro et al. (72), and Tetr recombinants were selected on M9
medium plates containing tetracycline.
Cloning and sequencing of T-POP insertions. Chromosomal DNA from back-
crossed mutants with T-POP insertions was digested with PstI, which did not
cleave within the T-POP element, and ligated to the PstI site of plasmid pSU19.
Ligation mixtures were electroporated into E. coli DH5, and transformants
were selected on LB medium plates containing oxytetracycline. Unlike tetracy-
cline, oxytetracycline does not induce transcription of the tetRA genes and can be
used to select for medium- or high-copy-number plasmids with subcloned T-POP
inserts. Plasmid DNAs were purified using QIAGEN columns and were used as
templates in PCRs with the T-POP-EX1 primer (CCTTTTTCCGTGATGGTA),
internal to the T-POP element and extending outward from tetR, to define the
serovar Typhi tsx zxx::T-POP insertion join points. This primer corresponded to
bp 2191 to 2207 in the GenBank accession no. AY150213 sequence. Mutant
alleles were designated by numbers corresponding to the coordinates in the
genome sequence of serovar Typhi strain CT18 (57) for the 9-bp direct repeat
generated by T-POP insertion. For the STY0014, STY2025, and STY1399 genes,
these coordinates are bp 15655 to 15663, 1898126 to 1898134, and 1351895 to
1351903, respectively.
RNA isolation and RT-PCR. To isolate RNA, cells were grown overnight in
LB medium at 37°C. Total RNA was extracted and purified using Trizol and was
treated with RNase-free DNase I (amplification grade; Gibco-BRL). Reverse
transcription (RT)-PCR was performed with 200 ng of DNase-treated RNA
using a single-tube RT-PCR kit (Gibco-BRL). Amplification was performed for
25 to 30 cycles (94°C for 30 s, 55°C for 30 s, and 72°C for 2 min, followed by a
7-min extension at 72°C). Primers GGGGAGTGCATCGACGCATT and TTT
ACTGCCACCGGCACAT, corresponding to internal region of the serovar
Typhi pyrD gene, were designed based on the CT18 genome sequence (57);
universal primers AGAGTTTGATCC TGGCTCAG and AAGGAGGTGATC
CAGCCGCA were used to amplify16S rRNA. Genomic DNA served as a pos-
itive control, and DNase-treated RNA that had not been reverse transcribed was
used as a negative control. Twenty-microliter aliquots removed after 25, 30, and
35 cycles of each PCR were electrophoresed on 1% agarose gels with ethidium
bromide, and the gels were analyzed using a Digital Science 120 system (Kodak).
The amounts of PCR products were normalized to the amounts of 16S rRNA
amplified in the cDNA samples.
Assays for the survival of serovar Typhi within human macrophage-derived
U937 cells. Infection of U937 cells was carried out as described by Baker et al.
(3), with the following modifications. Cells were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% (vol/vol) fetal bovine serum, seeded
into 24-well tissue culture plates at a concentration of 105 cells per well, and
activated with 100 nM phorbol myristate acetate. The cells were incubated for 2
days at 37°C in 5% CO2 and air, until a confluent monolayer was formed, and
then they were centrifuged and washed three times with PBS. Approximately 2
	 106 to 5 	 106 CFU of exponential-phase (OD600, 0.15 to 0.20) anaerobically
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grown bacteria was pelleted, washed twice with PBS, and resuspended in 1 ml of
minimal essential medium without nucleosides. Aliquots (100 l) of bacteria
were added to U937 cells at a multiplicity of infection of 20:1 to 50:1. After 1 h
of infection, cells were centrifuged and washed three times with PBS, and the
medium was replaced with Dulbecco’s modified Eagle’s medium supplemented
with 10% (vol/vol) fetal bovine serum containing gentamicin (200 g/ml). After
additional incubation for 2, 24, and 48 h, U937 cells were washed three times with
PBS and lysed with 0.5% deoxycholate, and the titers of intracellular bacteria
were determined by serial dilution of cell lysates on agar plates.
RESULTS
Expression of serovar Typhi Tsx and other porins is induced
in response to anaerobiosis. Previously, we found that the
ability of serovar Typhi to invade and proliferate within epi-
thelial and macrophage-like human cell lines is stimulated by
prior anaerobic growth (11). Because the proteins made by
serovar Typhi that first come in contact with host cells are
presented on the outer membrane, we reasoned that a subset
of outer membrane proteins made under anaerobic conditions
might contribute to the virulence of serovar Typhi.
To test this hypothesis, we identified a subset of the proteins
present in outer membrane fractions of serovar Typhi that are
expressed at higher steady-state levels under anaerobic condi-
tions, and we are attempting to assess the roles of these pro-
teins in virulence. A comparison of the proteins resolved by
one-dimensional SDS-polyacrylamide gel electrophoresis
present in outer membrane fractions of serovar Typhi grown
aerobically and anaerobically showed that expression of at
least five proteins found in the outer membrane fractions of
serovar Typhi cells is induced upon the shift to anaerobiosis
(Fig. 1). These proteins have mobilities corresponding to ap-
parent molecular masses of 50, 46, 44, 36, and 31 kDa (Table
2).
Previously, we have shown that the protein with an apparent
molecular mass of 36 kDa corresponds to the porin OmpC (12,
44). Bands corresponding to the other induced proteins were
isolated, and the N-terminal sequences of the proteins present
in these bands were determined by sequential Edman degra-
dation and are the sequences of serovar Typhi FliC (flagellin)
and the MalL, PhoE, and Tsx porins (Table 2).
Transcription of the serovar Typhi tsx gene increases in
response to anaerobiosis and is dependent on Fnr. Because
the majority of the regulation of prokaryotic gene expression
occurs at the level of transcription initiation, it is likely that the
increase in the level of Tsx porin in response to anaerobiosis is
due to the increased transcription of the tsx gene. To show that
transcription of the tsx gene is induced during anaerobiosis, we
constructed a transcriptional fusion of the tsx and lacZY genes
in single copy on the serovar Typhi genome, using FLP-medi-
ated site-specific recombination. Plasmid pCE36 was inte-
grated at the site of the “FLP scar” in the serovar Typhi tsx
strain (22). As shown in Fig. 2, the -galactosidase activity
produced by the recombinant serovar Typhi tsx::lacZY strain
during anaerobic growth was threefold higher than the activity
during aerobic growth. This result suggests that the increased
steady-state level of the Tsx protein observed under anaerobic
growth conditions is likely due to increased transcription of the
tsx gene.
Because Fnr regulates a global response to oxygen availabil-
ity at the level of transcription (36, 67, 68), we constructed an
fnr::Tn10 tsx::lacZY double mutant and measured the levels of
-galactosidase activity of the double mutant during aerobic
and anaerobic growth. As shown in Fig. 2, the presence of the
fnr::Tn10 allele abolished induction of -galactosidase activity
from the tsx::lacZY fusion under anaerobic conditions. This
result suggests that Fnr regulates the transcription of tsx. Be-
cause the two-component ArcAB system regulates the transi-
tion between aerobic and anaerobic respiratory control (67),
we also constructed an arcA::Tn10 tsx::lacZY double mutant
and measured the levels of -galactosidase activity of the dou-
ble mutant during aerobic and anaerobic growth. As shown in
FIG. 1. Profiles of proteins present in outer membrane fractions
extracted from serovar Typhi grown under aerobic and anaerobic con-
ditions are different. Proteins present in outer membrane fractions of
serovar Typhi were resolved by SDS-PAGE as described in Materials
and Methods. The steady-state levels of at least five proteins appear to
be higher when serovar Typhi is grown under anaerobic conditions.
TABLE 2. Amino-terminal sequences of proteins in the outer membrane fraction of Salmonella serovar Typhi induced by anaerobiosis
Proteina Locus tag N-terminal sequence
Mr (103)
Predicted Observed
FliC STY2167 AQVINTNSLSLLTQNNLNKSQXALGTAI 53.3 50
LamB STY4427 VDFHGYARSGIGWTG 50.1 46
PhoE STY0365 AEIYNKDGNKLDVIG 38.7 44
OmpC STY2493 Identified genetically 41.2 36
Tsx STY0451 AENDQPQYL 32.8 31
a The N-terminal sequences of the proteins shown in Fig. 1 with apparent molecular masses of 50, 46, 44, and 31 kDa were determined and found to match those
predicted from the Salmonella serovar Typhi flagellin and porin gene sequences. To confirm the identity of Tsx, we also sequenced the internal peptide, TFD-
WGNGNDK. The identity of the OmpC porin was determined by comparison of the outer membrane protein profiles of wild-type and mutant strains (12, 44).
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Fig. 2, the induction of the serovar Typhi tsx gene in response
to anaerobiosis is not dependent on the ArcAB two-compo-
nent system.
Deletion of the serovar Typhi tsx gene confers an auxotro-
phic requirement for nucleosides. To characterize the role that
the serovar Typhi tsx gene may play in the physiology and
virulence of serovar Typhi, we took a genetic approach. We
constructed a derivative of serovar Typhi with a deletion of the
tsx gene (tsx) and cloned the tsx gene into a plasmid vector to
complement the loss-of-function mutation. First, we con-
structed a mutant of serovar Typhi with a Camr cassette sub-
stituted for the tsx gene. Subsequently, the Camr cassette was
eliminated by FLP recombinase-mediated site-specific recom-
bination (17) to generate a serovar Typhi tsx strain. Figure 3
shows that the Tsx porin was not present in outer membrane
fractions isolated from this mutant.
In a subset of enteric gram-negative pathogens, Tsx has been
shown to be a nucleoside-specific porin that is dispensable for
growth in minimal media (52). However, we found that the
serovar Typhi tsx mutant was unable to grow in M9-glucose
or E-glucose minimal medium, and the efficiency of plating was
5 	 107 compared to the wild-type parent on M9-glucose
medium plates. In contrast, a serovar Typhimurium tsx mu-
tant was not an auxotroph and grew well in minimal media
(data not shown).
To confirm that this auxotrophy was due to loss of function
of the tsx gene, we amplified the serovar Typhi tsx gene using
a PCR and subcloned this gene into the medium-copy-number
plasmid pSU19. Plasmid pSU19::tsx was transformed into the
serovar Typhi tsx mutant, and we found that the serovar
Typhi tsx/pSU19::tsx recombinants could grow in minimal
medium (Table 3).
Because Tsx has been shown to be a porin involved in the
transport of nucleosides, we asked whether the addition of
nucleosides could mask the auxotrophy of the serovar Typhi
tsx mutant. We supplemented minimal medium with different
concentrations of nucleosides and nucleotide bases and found
that either adenosine or thymidine could correct the auxotro-
phy of the serovar Typhi tsx mutant (Table 4).
We also found that when the serovar Typhi tsx mutant was
grown on a minimal medium plate and a filter paper disk with
adenosine was placed in the center of the plate, a growth halo
formed around the disk. However, when serovar Typhi
FIG. 2. Induced expression of -galactosidase activity from a
tsx::lacZY fusion operon is dependent on Fnr. The data are the values
from one representative experiment performed in triplicate; similar
results were obtained in three additional, independent experiments.
Each point represents the arithmetic mean of three determinations of
-galactosidase activity expressed in Miller units (49).
FIG. 3. SDS-PAGE and two-dimensional profiles of serovar Typhi
wild-type and serovar Typhi tsx outer membrane fractions. Proteins
present in outer membrane fractions of serovar Typhi were resolved by
SDS-PAGE as described in Materials and Methods. (A) Results after
electrophoresis in one dimension. (B) Results after electrophoresis in
two dimensions. The arrow indicates the position of the Tsx porin.
TABLE 3. Efficiencies of platinga
Strain
Efficiency of
plating on
M9-Glc (%)
Salmonella serovar Typhi wild-type......................................... 1
Salmonella serovar Typhi tsx ................................................. 5 	 107
Salmonella serovar Typhi tsx/pSU19::tsx .............................. 1
Salmonella serovar Typhi nupC ............................................ 1
Salmonella serovar Typhi nupG ............................................ 1
Salmonella serovar Typhi nupC nupG ............................... 1
a Overnight cultures of each strain grown aerobically in LB medium at 37°C
were pelleted, washed twice with PBS, diluted serially in PBS, and spread on
M9-glucose medium (M9-Glc) plates. Numbers of CFU were determined after
incubation for 48 h at 37°C. Efficiencies of plating are expressed as the titer of
each strain divided by the titer of the wild type.
TABLE 4. Salmonella serovar Typhi tsx mutant is an auxotropha
Medium
Growth of:
Salmonella
serovar Typhi
wild type
Salmonella
serovar Typhi
tsx
Salmonella
serovar Typhi
tsx/pSU19::tsx
M9-Glc   
M9-Glc  guanosine   
M9-Glc  inosine   
M9-Glc  adenosine   
M9-Glc  uridine   
M9-Glc  cytidine   
M9-Glc  thymidine   
a Overnight cultures of each strain grown aerobically in LB medium at 37°C
were pelleted, washed twice with PBS, diluted serially in PBS, and spread on
M9-glucose medium (M9-Glc) plates supplemented with guanosine, inosine,
adenosine, uridine, cytidine, or thymidine at a final concentration of 0.5 mM.
, excellent growth after incubation for 48 h at 37°C; , good growth;
, poor growth; , barely visible growth; , no growth.
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tsx/pSU19::tsx was grown under the same conditions, a dis-
crete inhibition halo formed around the disk (Fig. 4). This
result suggests that whereas a high concentration of adenosine
is essential to support the growth of the serovar Typhi tsx
mutant, adenosine is toxic to otherwise isogenic cells express-
ing the tsx gene from a intermediate-copy-number plasmid.
Under the same conditions, the growth of wild-type serovar
Typhi was not affected by adenosine (data not shown).
We constructed tsx mutant derivatives of two additional
serovar Typhi strains, Ty2, whose genome sequence has been
determined (18), and another clinical isolate, STH795. Like
the STH2370 mutant, mutant derivatives of these strains were
auxotrophs, and their auxotrophies could be masked by addi-
tion of either adenosine or thymidine.
Survival of the serovar Typhi tsx mutant in human mac-
rophage-like U937 cells. U937 is a human monocytic suspen-
sion cell line (70), and the cells express many of the normal
macrophage characteristics when they are activated (31). Sur-
vival of Salmonella within macrophages is essential for viru-
lence (23) and involves a dynamic equilibrium between bacte-
rial growth and death (10). To determine whether the serovar
Typhi tsx mutant has an altered interaction with human mac-
rophages, we compared the survival of wild-type serovar Typhi
with the survival of the otherwise isogenic tsx mutant strain in
activated U937 cells. As shown in Fig. 5, the number of wild-
type bacteria recovered from infected U937 cells decreased
during the first 24 h after infection and then increased slightly
during the next 24 h. In contrast, the titers of serovar Typhi
tsx mutant bacteria recovered from U937 cells decreased
throughout the first 48 h of infection. Complementation of the
tsx mutant with the plasmid carrying the serovar Typhi tsx
gene resulted in an intermediate phenotype (Fig. 5). This find-
ing is consistent with the finding that complementation of
auxotrophy by this plasmid also did not result in a wild-type
phenotype; the complemented strain, unlike the wild type, did
not grow in the presence of high concentrations of adenosine.
Insertion of transposon T-POP upstream of the serovar
Typhi pyrD gene suppresses the auxotrophy of the tsx mu-
tant. The auxotrophy resulting from the tsx mutation is sur-
prising for four reasons. First, deletion of no other porin-
encoding gene in gram-negative bacteria closely related to
serovar Typhi, including other serovars of S. enterica and E.
coli, results in auxotrophy. Salmonella serovar Typhi strains
with mutations in the porin-encoding ompC, ompF, and ompA
genes grow on minimal medium (unpublished results). Second,
the tsx mutation, unlike mutations in the essential purine and
pyrimidine biosynthetic pathways of S. enterica, causes auxot-
rophy that can be masked by the addition of nucleosides but
not by the addition of their nucleotide counterparts. Third, the
tsx mutation causes auxotrophy that can be masked by the
addition of either purine or pyrimidine nucleosides (adenosine
or thymidine). Fourth, the tsx mutation causes auxotrophy
that can be masked by the addition of specific purine and
pyrimidine nucleosides. Adenosine and thymidine work, but
why don’t guanosine and uridine work? And why do these
particular nucleosides reflect the substrate specificity of the
Tsx porin? This phenotype is clearly novel among auxotrophs
of S. enterica.
To address this puzzle, we took a genetic approach. We
reasoned that a study of reversion mutations that suppress this
phenotype might allow us to understand why a serovar Typhi
tsx mutant is an auxotroph. Because deletion of no other
porin-encoding gene in gram-negative enteric bacteria closely
related to serovar Typhi results in auxotrophy, including dele-
tion of the serovar Typhimurium tsx gene (unpublished re-
sults), we reasoned that serovar Typhi may have an additional
gene function missing in serovar Typhimurium that makes tsx
an essential gene. To test this hypothesis, we looked for loss-
of-function mutations in these genes that suppressed the auxo-
trophic defects of a tsx mutation. Success in our efforts would
have supported our rejection of the alternative hypothesis that
serovar Typhi is missing a gene function present in serovar
Typhimurium, the absence of which makes tsx essential.
FIG. 4. Adenosine masks the auxotrophy of the mutant serovar
Typhi tsx strain. Overnight cultures of the serovar Typhi tsx and
serovar Typhi tsx/pSU19::tsx strains were grown aerobically in LB
medium at 37°C, pelleted, washed twice with PBS, and diluted 100-fold
in PBS. Two hundred microliters of each dilution was spread on an
M9-glucose agar plate. A sterile paper disk with 20 l of 100 mM
adenosine was placed in the center each plate, and the plates were
incubated at 37°C for 48 h. The red lines indicate the diameters of the
growth halo of the serovar Typhi tsx strain and the inhibition halo of
the serovar Typhi tsx/pSU19::tsx strain.
FIG. 5. Survival of the serovar Typhi wild-type (}), serovar Typhi
tsx (■), and serovar Typhi tsx/pSU19::tsx (Œ) strains in human U937
cells. Salmonella serovar Typhi cells were placed in direct contact with
U937 cells by brief centrifugation of tissue culture plates after mixing.
After 1 h of incubation at 37°C, extracellular bacteria were removed by
washing with PBS, and the remaining extracellular bacteria were killed
by addition of gentamicin to the growth medium. Intracellular bacte-
rial survival was determined by serial dilution of cell lysates, followed
by growth of serial dilutions on LB medium plates at 37°C for 48 h. The
correlation between time and intracellular survival was established in
four independent experiments performed in triplicate. Each point rep-
resents the arithmetic mean of three determinations, expressed as
number of CFU/well.
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To look for mutations in the gene(s) that makes tsx essential
in serovar Typhi but not in serovar Typhimurium, we looked
for transposon insertions that inactivated genes, whose loss of
function suppressed the tsx defect. Recently, we have shown
that insertion of the transposon T-POP can be used to identify
essential serovar Typhi genes by placing their expression under
the control of the tetracycline-inducible tetA promoter (32).
The T-POP element carries the tetR (repressor) and tetA (re-
sistance) genes flanked by active IS10 inverted repeats re-
quired in cis for transposition. Tetracycline induces divergent
transcription of tetR and tetA, which can extend outside the
ends of the transposon into adjacent genes (58).
We isolated derivatives of the serovar Typhi tsx mutant
strain with insertions of the T-POP element and selected
among these derivatives for tetracycline-resistant prototrophs.
Sequence analysis of the T-POP insertion present in one such
revertant showed that the insertion was within the STY2025
gene, which is predicted to encode a tail protein of a lambdoid
prophage.
To demonstrate that this insertion is responsible for the
suppression of the auxotrophic phenotype of the serovar Typhi
tsx mutant, the insertion was backcrossed into the mutant
strain by electroporation with linear DNA. As shown in Fig. 6,
the STH2370 tsx STY2025::T-POP double mutant grew at the
same rate as the wild type on M9-glucose medium with tetra-
cycline at a concentration of 0.5 g ml1. This strain did not
grow in the absence of tetracycline, suggesting that expression
of a nearby chromosomal gene from the divergent tetRA pro-
moters in this strain is required for suppression. Surprisingly,
this strain also did not grow when the medium was supple-
mented with tetracycline at a concentration of 2 g/ml1 or
more, suggesting that the overexpression of a nearby chromo-
somal gene from the divergent tetRA promoters in this strain is
toxic to serovar Typhi.
The prophage in which this suppressing T-POP insertion is
located is integrated at two different sites in the two sequenced
genomes of serovar Typhi, the genomes of strains CT18 and
Ty2 (18, 57). The results of PCR amplifications across the
prophage attL and attR sites using STH2370 chromosomal
DNA as the template showed that the site of integration of this
prophage in STH2370 is the same as that in strain Ty2 (un-
published results) and corresponds to the site of integration of
the serovar Typhimurium lambdoid prophage Gifsy-2 (34).
Examination of the region of the serovar Typhi genome with
this T-POP insertion revealed that it contains only one gene
known to be involved in nucleoside transport or metabolism,
pyrD, which encodes dihydroorotate dehydrogenase, the only
membrane-associated protein involved in nucleoside biosyn-
thesis (Fig. 7). The site of prophage integration lies three genes
upstream of pyrD (t1862 in the Ty2 genome sequence), which
places the T-POP insertion in STY2025 (corresponding to the
t1879 locus in the Ty2 genome sequence) about 14 kb up-
stream of pyrD. Therefore, we formed the hypothesis that
overexpression of the pyrD gene from the tetA promoter in the
STH2370 tsx STY2025::T-POP double mutant may suppress
the tsx defect, because it restored an essential balance of prod-
ucts of the tsx and pyrD genes.
To test this hypothesis, we asked whether expression of the
pyrD gene is altered in the double mutant at different concen-
trations of inducer and used RT-PCR to measure the relative
levels of the pyrD gene transcript in the presence or absence of
inducer. Surprisingly, we found that transcripts corresponding
to the pyrD gene were produced at higher levels in the absence
of inducer than in its presence (Fig. 8). Thus, it appears that
the induced transcription in the direction of the pyrD gene
from the tetA promoter results in decreased, not increased,
expression of pyrD. If this is the case, then the failure of the
tsx STY2025::T-POP double mutant to grow at high concen-
trations of inducer may be simply due to the loss of pyrD
FIG. 6. Growth of the serovar Typhi tsx STY2025::T-POP double
mutant is dependent on the presence of inducer. Overnight cultures of
the serovar Typhi wild-type (E), serovar Typhi tsx (), and serovar
Typhi tsx STY2025::T-POP (‚) strains were grown aerobically at
37°C in LB medium, pelleted, washed twice with PBS, and diluted
100-fold in PBS. Two hundred microliters of each dilution was subcul-
tured in 30 ml of M9-glucose medium. Œ and ■, growth of the serovar
Typhi tsx STY2025::T-POP mutant in M9-glucose medium with 0.5
and 2 g ml1 of tetracycline, respectively. Results of a representative
experiment are shown; similar results were observed in three indepen-
dent experiments and experiments in which the nontoxic inducer chlor-
tetracycline was added.
FIG. 7. Insertion of T-POP in the serovar Typhi STY2025 locus,
upstream of pyrD, suppresses the auxotrophy resulting from the tsx
mutation. The join point of the T-POP insertion in the STY2025 locus
was determined using a primer internal to the T-POP element and
extending outward from tetR. The diagram shows that this gene is part
of a 69-kb lambdoid prophage integrated at a site adjacent to the pyrD
gene. This region of the serovar Typhi STH2370 genome is conserved
with the corresponding region of strain Ty2. In this region of the
sequenced Ty2 genome, the prophage t1879 locus (bp 1939277 to
1938267), identical to STY2025 in strain CT18, lies 14 kb upstream of
the pyrD gene (t1862; bp 1924812 to 1923802) (18). The T-POP inser-
tion places pyrD gene expression under control of the tetA promoter.
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expression under these conditions, resulting in pyrimidine aux-
otrophy. Consistent with this idea, we found that growth of the
tsx STY2025::T-POP double mutant was restored in the pres-
ence of high concentrations of inducer by the addition of uri-
dine, unlike what happens with its tsx parental strain (Table
4). Uridine also satisfies the auxotrophic requirement of a
serovar Typhi pyrD::Tn10 mutant (unpublished results).
In addition, we isolated and characterized two additional
T-POP insertions that suppress the phenotype of the tsx mu-
tation. These insertions lie within the STY0014 and STY1399
genes, which are predicted to encode a helix-turn-helix protein
in the LysR family of transcription regulators and a protein
with an unknown function, respectively.
DISCUSSION
The porin Tsx is among the serovar Typhi outer membrane
proteins that are induced in response to anaerobiosis. We
found that expression of the serovar Typhi tsx gene is regulated
by Fnr but not by the ArcAB system. This is consistent with
results that show that although the subsets of E. coli genes
controlled by Fnr and ArcAB overlap extensively, the Fnr
regulon includes a set of genes expressed under strictly anaer-
obic conditions that are not controlled by ArcAB (60). In E.
coli, expression of tsx is controlled by two differentially regu-
lated promoters. One promoter is subject to negative regula-
tion by both the DeoR and CytR repressors, and the other is
positively regulated by the cyclic AMP/cyclic AMP receptor
protein complex (7, 8, 29). These elements are conserved in the
serovar Typhi tsx promoter sequence. In addition, the se-
quence of the serovar Typhi tsx promoter also contains two
inverted repeats corresponding to Fnr consensus binding sites
(TTGATNNNNATCAA) (63), 77 bp upstream of its DeoR
operator.
Surprisingly, we found that deletion of the serovar Typhi tsx
gene confers an auxotrophic requirement for adenosine or
thymidine. Prototrophy can be restored by complementation of
a tsx mutant with an intermediate-copy-number plasmid car-
rying the tsx gene, but the complemented strain acquires sen-
sitivity to the nucleosides, presumably as a consequence of
overexpression of tsx. It is not surprising that the serovar Typhi
tsx mutant is unable to survive as well as its wild-type parent
in human cells. Many of the genes required for the pathoge-
nicity of serovars of S. enterica encode proteins involved in
normal housekeeping functions of the bacillus, including genes
involved in purine and amino acid biosynthesis, as well as genes
involved in nutrient uptake. Mutations in these housekeeping
genes can attenuate the virulence of Salmonella and at the
same time allow the immune system to clear infecting organ-
isms more rapidly. Mutants of serovar Typhimurium with
auxotrophic requirements for nucleosides are attenuated in
vivo, most likely because serovar Typhimurium encounters a
scarcity of nucleosides and nucleotide bases within macro-
phages (23, 41, 47, 56).
Why is the serovar Typhi tsx mutant an auxotroph for these
nucleosides? In both E. coli K-12 (52) and serovar Typhi-
murium (unpublished results), deletions of the tsx gene do not
confer auxotrophy, and the importance of the Tsx protein for
nucleoside uptake becomes apparent only at low substrate
concentrations (
1 M) (26). This auxotrophy does appear to
reflect the substrate specificity of the Tsx porin. In E. coli, the
rate of uptake of adenosine and thymidine is strongly reduced
in the absence of the Tsx porin, whereas the rate of uptake of
cytidine remains unchanged (51).
Clearly, the tsx mutation must result in a defect in the
transport of nucleosides across the outer membrane. However,
the auxotrophy resulting from the tsx mutation is not an
auxotrophy in the classical sense, for the four reasons de-
scribed above, and the growth defect caused by the tsx mu-
tation is unlikely to be a consequence of its function in nucle-
oside transport per se. In support of this idea, we have shown
that serovar Typhi nupC and nupG mutants, as well as a nupC
nupG double mutant defective in the two major inner mem-
brane nucleoside permeases conserved among the gram-nega-
tive enteric bacteria, retain the ability to grow in minimal media.
Rather, our results suggest that the tsx gene product must
play a critical role in the assembly or integrity of the serovar
Typhi membrane. This hypothesis is consistent with the finding
that overexpression of Tsx is detrimental to growth in the
presence of its preferred substrates. Recent studies of the
mechanisms of colicin transport across the outer membrane
suggest that porins such as Tsx may participate in assembly of
translocon complexes involving other outer membrane pro-
teins (74) and other periplasmic and inner membrane proteins
(59). Thus, Tsx may be required for assembly of an essential
translocon complex, and perhaps the conformational changes
that an alternative porin, such as OmpF or OmpC, undergo
FIG. 8. Expression of pyrD in the tsx STY2025::T-POP double
mutant decreases in response to increasing concentrations of inducer.
RNA was isolated from overnight cultures grown aerobically in LB
medium at 37°C. RT-PCR was used to determine the relative amounts
of pyrD mRNA (band I) and 16S rRNA (band II). Lane A, serovar
Typhi wild type; lane B, serovar Typhi tsx STY2025::T-POP; lane C,
serovar Typhi tsx STY2025::T-POP with 0.5 g ml1 chlortetracy-
cline; lane D, serovar Typhi tsx STY2025::T-POP with 10 g ml1
chlortetracycline. The relative amount of transcript corresponding to
an internal portion of the pyrD gene decreased about twofold upon
addition of low concentrations of the nontoxic inducer chlortetracy-
cline and more than fivefold upon addition of high concentrations of
chlortetracycline.
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during nucleoside transport may allow it to substitute for the
essential role of Tsx. Alternatively, the absence of the Tsx
protein may result in the formation of a complex detrimental
to cell growth, by facilitating the interaction between two mem-
brane proteins whose abnormal association can be disrupted by
the restoration of nucleoside transport. Tsx may play an im-
portant role in cell structure, because in E. coli K-12, the Tsx
protein is enriched in minicells (38) and may play a role in
maintaining the integrity of the cell poles.
The analysis of second-site revertants of the tsx mutant
provides an initial clue about the nature of the complex in
which Tsx participates; PyrD may be a part of this complex.
Decreased expression of the pyrD gene from the tetA promoter
in the presence of intermediate concentrations of tetracycline
suppresses the defect caused by the tsx mutation. Expression
of the serovar Typhimurium pyrD gene is regulated in response
to the ratio of intracellular CTP to intracellular GTP. Under
repressing conditions, when this ratio is high, the pyrD tran-
script initiates upstream of its preferred starting point under
inducing conditions, when the ratio is low. The longer tran-
script begins with a stem-loop structure (attenuator) that may
sequester the pyrD start codon, thereby preventing efficient
translation of the pyrD gene product (65, 66); this attenuator is
also present upstream of the serovar Typhi pyrD gene. Our
results suggest that the regulation of pyrD transcription is more
complicated and that transcripts initiating from the tetA pro-
moter extending into the pyrD attenuator either may terminate
prematurely or may be degraded more rapidly, because our
RT-PCR analyses showed that less transcript corresponding to
an internal region of the pyrD gene is made when expression of
pyrD from the upstream tetA promoter is induced.
The finding that the tsx STY2025::T-POP double mutant
displays different growth phenotypes at three different concen-
trations of inducer shows that the induced expression of genes
from the tetA promoter is not an all-or-nothing phenomenon
but rather is rheostatic. Only intermediate levels of pyrD ex-
pression from the tetA promoter suppress the tsx defect, in-
dicating that the balance of products of the tsx and pyrD genes
is critical for the growth of serovar Typhi. Therefore, it is not
surprising that one of the additional second-site suppressors of
the tsx mutation is an insertion of T-POP into the STY0014
locus, which is predicted to encode a regulator of transcription.
Presumably, this regulatory mutation affects the balance of the
tsx and pyrD gene products. Unfortunately, the two genes in
which these additional T-POP insertions map are unique to the
genomes of serovars Typhi, Paratyphi A, and Typhimurium,
and we cannot obtain clues about their functions from com-
parative genomics. We must conduct additional genetic studies
to identify their roles in nucleoside transport and biosynthesis.
Our hypothesis that the growth of serovar Typhi is depen-
dent on a balance of products involved in nucleoside transport
and biosynthesis is supported by the fact that this is not the
only reported case in which an imbalance of such products
results in a growth defect. When the NupG inner membrane
transporter is expressed from a high-copy-number plasmid in
E. coli, high concentrations of adenosine inhibit cell growth
(55). Finally, if PyrD, a protein associated with the inner mem-
brane, forms part of a translocon complex with Tsx, an outer
membrane porin, then there likely is an inner membrane pro-
tein that can bridge these two components. Preliminary results
from additional genetic experiments have allowed us to iden-
tify a candidate for such a third, integral inner membrane
component.
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